Toronto Dominion Bank Vertex Pharmaceuticals Inc Transaction History

Toronto Dominion Bank

$61.6 Billion
Q2 2024

A detailed history of Toronto Dominion Bank transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Toronto Dominion Bank holds 131,106 shares of VRTX stock, worth $65.9 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

131,106

Previous 152,959 14.29%

Holding current value

$65.9 Million

Previous $63.9 Million 3.89%

% of portfolio

0.1%

Previous 0.1%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $8.58 Million - $10.6 Million	-21,853 Reduced 14.29%	131,106 $61.5 Million
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $1.2 Million - $1.32 Million	2,950 Added 1.97%	152,959 $63.9 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $4.73 Million - $5.67 Million	13,796 Added 10.13%	150,009 $61 Million
Q3 2023 Feb 14, 2024	SELL	$338.18 - $362.46 $1.27 Million - $1.36 Million	-3,742 Reduced 2.67%	136,213 $47.4 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $1.27 Million - $1.36 Million	-3,742 Reduced 2.67%	136,213 $47.4 Million
Q2 2023 Feb 14, 2024	SELL	$314.42 - $351.91 $3.16 Million - $3.54 Million	-10,054 Reduced 6.7%	139,955 $49.2 Million
Q2 2023 Aug 10, 2023	BUY	$314.42 - $351.91 $3.41 Million - $3.82 Million	10,851 Added 8.4%	139,955 $49.2 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $2.05 Million - $2.33 Million	-7,226 Reduced 5.3%	129,104 $40.7 Million
Q4 2022 Feb 07, 2023	BUY	$285.76 - $321.48 $5.77 Million - $6.49 Million	20,190 Added 17.38%	136,330 $39.3 Million
Q3 2022 Nov 09, 2022	SELL	$273.83 - $305.53 $2.69 Million - $3 Million	-9,809 Reduced 7.79%	116,140 $33.6 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $1.23 Million - $1.53 Million	-5,223 Reduced 3.98%	125,949 $35.5 Million
Q1 2022 May 09, 2022	SELL	$221.42 - $260.97 $5.34 Million - $6.29 Million	-24,109 Reduced 15.53%	131,172 $34.2 Million
Q4 2021 Feb 04, 2022	SELL	$177.01 - $223.45 $12.3 Million - $15.5 Million	-69,234 Reduced 30.84%	155,281 $34.1 Million
Q3 2021 Nov 08, 2021	BUY	$181.39 - $202.99 $5.91 Million - $6.61 Million	32,565 Added 16.97%	224,515 $40.7 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $36 Million - $42.4 Million	191,950 New	191,950 $38.7 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.

Account

Toronto Dominion Bank Vertex Pharmaceuticals Inc Transaction History